Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioventix Regulatory News (BVXP)

Share Price Information for Bioventix (BVXP)

Share Price is delayed by 15 minutes
Get Live Data
1,675.00    -25.00 (-1.47%)
Bid:
1,650.00
Ask:
1,700.00
Spread: 50.00 (3.03%)
Market Cap: £87.52m
BVXP Live PriceLast checked at - London Stock Exchange

Intraday Bioventix Share Chart

Holding(s) in Company

16 Jan 2015 16:44

BIOVENTIX PLC - Holding(s) in Company

BIOVENTIX PLC - Holding(s) in Company

PR Newswire

London, January 16

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or the underlying issuerof existing shares to which voting rights are Bioventix Plcattached:ii 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal of qualifying financial instruments which may resultin the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect toqualifying financial instruments An event changing the breakdown of voting rights Other (please specify): 3. Full name of person(s) subject to the Hargreave Hale Limitednotification obligation:iii 4. Full name of shareholder(s) Discretionary Clients (if different from 3.):iv 5. Date of the transaction and date onwhich the threshold is crossed or 09/05/14reached: v 6. Date on which issuer notified: 12/05/14 7. Threshold(s) that is/are crossed or 5%reached: vi, vii 8. Notified details: A: Voting rights attached to shares viii, ix Class/type Situation previous Resulting situation after the triggering transactionof to the triggeringshares transaction if possible Number Number Number Number of voting % of voting rights xusing of of of shares rightsthe ISIN Shares VotingCODE Rights Direct Indirect Direct xi Indirect xii Direct Indirect GB00B4QVDF07 245,000 245,000 259,405 259,405 5.1426% B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of votinginstrument date xiii Conversion Period xiv rights that may be rights acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying FinancialInstruments xv, xvi Resulting situation after the triggering transaction Type of Exercise price Expiration Exercise/ Number of voting rights % of voting rightsfinancial date xvii Conversion instrument refers to xix, xxinstrument period xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 259,405 5.1426% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi All of these shares are held for a unit trust operated by Marlborough FundManagers Ltd, for whom Hargreave Hale Ltd manages the investments on adiscretionary basis. Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will ceaseto hold: 12. Date on which proxy holder will cease to holdvoting rights: 13. Additional information: 14. Contact name: David Clueit 15. Contact telephone number: 01253 754739
Date   Source Headline
18th May 20268:45 amRNSHolding(s) in Company
28th Apr 20263:45 pmRNSDirector Dealing
20th Apr 202611:54 amRNSShare Options Awarded
13th Apr 20267:00 amRNSDirector Dealing
8th Apr 20264:20 pmRNSDirector Dealing
30th Mar 20267:00 amRNSInterim Results
24th Feb 20267:00 amRNSAppointment of Non-Executive Director
4th Dec 20253:59 pmRNSResult of AGM
26th Nov 20258:50 amRNSDirector Dealing
11th Nov 20257:00 amRNSPosting of Annual Report and Notice of AGM
4th Nov 20254:12 pmRNSDirector Dealing
30th Oct 20257:00 amRNSDirector Dealing
27th Oct 20253:53 pmRNSDirector Dealing
27th Oct 20257:00 amRNSResults for the year ended 30 June 2025
13th Aug 20252:19 pmRNSHolding(s) in Company
28th Apr 20255:13 pmRNSDirector Dealing
11th Apr 20257:00 amRNSExercise of Options and Issue of Equity
31st Mar 20257:00 amRNSInterim Results
24th Dec 20249:14 amRNSDirector Dealing
6th Dec 20247:00 amRNSResult of AGM
4th Dec 20243:34 pmRNSHolding(s) in Company
22nd Nov 20243:56 pmRNSDirector/PDMR Shareholding
8th Nov 20247:57 amRNSNotice of AGM
31st Oct 20247:00 amRNSDirector/PDMR Shareholding
28th Oct 20247:00 amRNSResults for the year ended 30 June 2024
25th Oct 202410:37 amRNSHolding(s) in Company
16th Oct 20241:51 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 202411:05 amRNSHolding(s) in Company
25th Mar 20247:00 amRNSInterim Results
29th Jan 20243:15 pmRNSDirector/PDMR Shareholding
7th Dec 20233:26 pmRNSResult of AGM
28th Nov 20233:26 pmRNSDirector/PDMR Shareholding
16th Nov 202312:40 pmRNSHolding(s) in Company
10th Nov 20234:23 pmRNSPosting of Annual Report and Notice of AGM
7th Nov 202312:07 pmRNSHolding(s) in Company
1st Nov 20234:07 pmRNSHolding(s) in Company
30th Oct 20237:00 amRNSResults for the year ended 30 June 2023
25th Sep 20234:28 pmRNSHolding(s) in Company
19th Sep 20232:29 pmRNSHolding(s) in Company
24th Jul 20237:00 amRNSHolding(s) in Company
6th Jul 20232:48 pmRNSHolding(s) in Company
30th May 20237:00 amRNSBoard Appointment
19th May 20237:00 amRNSDirector/PDMR Shareholdings and Issue of Equity
25th Apr 202310:35 amRNSDirector/PDMR Shareholding
11th Apr 20232:45 pmRNSHolding(s) in Company
31st Mar 20232:45 pmRNSDirector/PDMR Shareholding
27th Mar 20237:00 amRNSInterim Statement
8th Mar 20235:50 pmRNSHolding(s) in Company
31st Jan 20235:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.